leeds city council executive board webcast

Before coming to ASCO full-time, he was the Chief of the Breast Medicine Service at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and Professor of Medicine at the Weill Medical College of Cornell University. He was a member of the Board of Directors of Loxo Oncology prior to its acquisition by Eli Lilly in early 2019. In this role, he was responsible for all aspects of gRED innovation, drug discovery and development. Learn how University of Maryland, using Digital Twins, solves the real problem of how to give students the individual experience and training they need when it isn’t possible to go into a physical lab. Among his scientific contributions, he has helped highlight new biological mechanisms underlying heart attack, discovered mutations that protect against heart attack risk, and developed a genetic test for personalized heart attack prevention. expected to rise to 9.7 billion, with 2 billion over the age of 60. Luxembourg, February 11 (ANI): Aditya Mittal will take over as Chief Executive Officer of ArcelorMittal, the world's leading steel and mining company his father Lakshmi N Mittal founded in 1976. You can now save presentations to a watch later list and revisit them at your convenience. Imago, a privately held pharmaceutical company, engaged in development of drug candidates directed against JNK for fibrosis and neurodegenerative disease treatment. Michal serves on the Scientific Advisory Boards FutuRx Accelerator, and was, until recently, a member of the SAB of Prize4Life and a Member of the Board of Directors of a number of companies, including Compugen and Alma Lasers. Dr. Bahija Jallal is Chief Executive Officer and Director of the Board of Immunocore. The system consists of several projects that students can access from any browser and actuate and redirect signals on various experiments while obtaining quantitative data. This is combined with additional support for responding to Covid-19 to allow the Local Authority to explore and understand how companies are or will be returning to their workplaces. Under his leadership, WuXi Biologics has built a world-class open-access integrated biologics discovery, development and manufacturing platform enabling a full spectrum of companies ranging from boutique virtual enterprises to Top 20 global pharmaceutical companies. Receive our newsletter and information on upcoming events. A property management portfolio is made up of physical buildings. Dr. Soll is currently a board member at Simcha Therapeutics, an board observer at the Accelerator Life Science Parnters, and an advisory board member with the Blavatnik Center for Drug Discovery at Tel Aviv University, the Children’s Tumor Foundation, and the Pistoia Alliance. Hui Cai, Forum Chair; VP and Head of Content Division, WuXi AppTec, 8:05 Opening Remarks All Rights Reserved. He joined Polaris in 2002 and focuses on investments in healthcare. from Harvard Medical School. Dr. Rudolph Tanzi is the Director of the Genetics and Aging Research Unit, Co-Director of the McCance Center for Brain Health, Co-Director of the MassGeneral Insititute for Neurodegenerative Disease, and Vice-Chair of Neurology (Research), at Massachusetts General Hospital. Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S. degree in analytical chemistry and B.S. Learn how simulation-based digital twins are helping companies better analyze machines in real-world operating conditions, allowing them to make informed decisions and improve their performance far above what is possible today. But BIM is limited by the input provided to it by all the stakeholders. He was made OBE for services to innovation in 2017. He has been on the board of directors and scientific advisory boards, including Ferring Pharmaceuticals (U.S. Division), Rubius Therapeutics, Brooks Automation and several biotech start-ups. Discover how combining machine connectivity with engineering simulation in a scalable approach enables organizations to perform diagnostics and troubleshooting. She lives in the San Francisco Bay Area with her husband and two children. This session will explore their ship crane simulator, which is based on a digital twin of the latest machine model. He completed his clinical training in internal medicine and cardiology at MGH and his postdoctoral research training in human genetics at the Framingham Heart Study and the Broad Institute. He is a leading figure in the development of regulatory T cell therapies. She Focused on agility and pioneering science, Dr. Varney built a team-based organization that today produces more that 40% of Genentech’s development portfolio, including the marketed anticancer agents Erivedge and Cotellic. One, Limited. Asset owners look at Digital Twin lifecycle as the use of the Digital Twin during the lifecycle phases of an asset, from planning, construction/manufacturing, operating, maintaining, and retiring the asset. He was the founding Intrigued by the observation that the path from great basic discoveries to equally great clinical benefit is bumpy and often inefficient, she joined the Children’s Tumor Foundation (CTF) in order to try to smooth this path for neurofibromatosis, a rare genetic disorder. medicinal chemistry, drug discovery and protein degradation. Ameet Nathwani, CEO, Dewpoint Therapeutics Arnaud Bernaert believes indeed that in the next decade, Healthcare in human biology from Stanford University. Howard Federoff, CEO, Aspen Neuroscience She holds a Ph.D. in Biological Sciences from the Weizmann Institute of Science, an MBA from INSEAD, Fontainebleau, France, and a BA in Medicine from Hadassah Medical School, Hebrew University, Jerusalem. The concept of the digital twin emerged several years ago with the advent of the industrial IoT and smart connected factories, plants, and production systems. Prior to Takeda, Dr. Hitchcock had served in senior leadership positions in the research organizations at Eli Lilly and Amgen. Christian Schneider, liebherr Werk Nenzing. In this capacity, nearly 2,000 physicians and scientists reported to José , and under his leadership, MSK become the leader in early phase clinical trials for cancer therapies and diagnostic genetic sequencing. Academy of Arts and Sciences, was the Ludwig Professor at the University of Chicago and received They are driven by optimizing turbine output while respecting regulatory boundaries to minimize impact on the surrounding industrial area. investors. Kate is co-leads biotech investments and activities in the UK (and EU) and serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. Prior to joining Sanofi, Ameet was the Global Head of Medical Affairs and a member of the Pharma Executive Committee at Novartis Pharma AG, where he led the establishment of a Real World Evidence Center of Excellence and Digital Medicine capabilities. A nationally and internationally recognized leader in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf is a graduate of Duke University School of Medicine. Kartik Ramamoorthi, PhD, is Chief Executive Officer & Co-Founder of Encoded Therapeutics. Maintenance teams, cleaners, delivery people, emergency resimusponders and property owners need access to shared spaces, yet with more keys issued, it is harder to maintain trust in the system and prevent, detect, or deter abuse of privilege. Vice Chairman and Global Chief Investment Officer at WuXi AppTec. He also served in several other leadership roles at UHN, including vice chair of Research for the University of Toronto's Department of Radiation Oncology, founding director of the STTARR Innovation Centre, and founding director of the Techna Institute for the Advancement of Technology for Health. He sits on the UK’s Life Sciences Council and Life Sciences Industrial Strategy Implementation Board. Howard is an elected Fellow of the AAAS and National Academy of Inventors. Richard Ferris, Head of Engineering, Lendlease, and John Turner, VP of Innovative Solutions, Gafcon. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. What if there was a way to build and maintain infrastructure with greater certainty? With the rise of simulation and modelling coupled with artificial intelligence and machine learning it is now possible to look to the future: predict, anticipate, adapt and automate. This keynote address will explore the possibilities being created by the digital twin economy. Now over thirty years old, OMG began as a standards development organization, publishing standards such as CORBA and UML. A successful entrepreneur, Ms. Zohar created PureTech, assembling a leading team to help implement her vision for the Company, and was a key participant in fundraising, business development and establishing the underlying programs and platforms that have resulted in PureTech’s substantial pipeline, which is comprised of 24 products and product candidates, including two that have received US Food and Drug Administration (FDA) clearance and European marketing authorization. Thank you for tuning into our programs, and a special thank you to our WuXi Global Forum 2021 partners: BioCentury, BioIndustry Association, BioWorld, Biocom, California Life Sciences Association, Children’s Tumor Foundation, Endpoints News, MBC BioLabs, Pharma Intelligence | informa, QB3 and Swiss Biotech Association. Dr. Tanzi has published roughly 600 papers, has received numerous awards including the Metropolitan Life Award, Potamkin Prize, Smithsonian American Ingenuity Award, and was on the 2015 TIME100 Most Influential People in the World list. Additionally, Amir has served as a director of Adnexus Therapeutics (Bristol Myers Squibb), Athenix Corporation (Bayer), Avila Therapeutics (Celgene), Fate Therapeutics (NASDAQ: FATE), Living Proof (Unilever), Promedior Pharmaceuticals, Receptos (Celgene), Selecta Biosciences (NASDAQ: SELB), Sun Catalytix (Lockheed Martin), and TARIS Biomedical (J&J). Aviv Regev joined Genentech in August 2020 as Executive Vice President, Genentech Research and Early Development. Learn everything an expat should know about managing finances in Germany, including bank accounts, paying taxes, getting insurance and investing. This was always the case with mechanical and electronic locks and now internet connected door locks present new challenges and introduce cyber-physical risks. Amir is a managing partner in Polaris’ Boston office. Dick Slansky Senior Analyst - PLM/Engineering Tools for Plant Design & Infrastructure at ARC Advisory Group. unsustainable and ineffective. Digital twins are fast becoming a core component in all industry verticals, helping organizations to gain the upper hand on their competition by creating better processes for their product and/or service development. addressed as key note speaker, panelist, moderator or knowledge Barbara’s pharmaceutical career started in the Immunology Division of Smith Kline & French Research Laboratories. Before coming to UC Irvine, Howard served as the Executive Vice President for Health Sciences at Georgetown University and Executive Dean of Medicine at Georgetown University. You are confirmed to attend for free on BrightTALK! Dr. Shawver is the Founder of The Clearity Foundation, a nonprofit organization helping women with ovarian cancer to improve their treatment options and currently serves on the board of Relay, Nkarta, and Cleave Therapeutics. coalitions in fields as diverse as epidemics preparedness, vaccines His research and clinical achievements have led to the creation of a number of biopharmaceutical companies, and he is an international thought leader for innovation in cancer care and clinical research. The Industrial Internet Consortium (IIC) established seven years ago, and Digital Twin Consortium last year. Join us for an update on the project, along with a discussion on the important lessons learned along the way, on what is set to become a step change in urban planning. As the founding investor of a16z’s Bio Fund, Pande leads the firm’s investments at the cross section of biology and computer science, including applications in computation, machine learning, and artificial intelligence in healthcare; digital therapeutics; diagnostics; and other novel transformative scientific advances applied to industry that take bio beyond healthcare. His earlier career spanned managerial and financial positions at Biogen and Merck respectively. Aviv Regev, Head, Genentech Research and Early Development In 2020, she was the recipient of several accolades including the Lurie Prize in Biomedical Sciences, Massachusetts General Hospital’s Jonathan Kraft Prize, and the European Society of Human Genetics’ Mendel Award. The global trade body announced Tuesday that it would hold a special meeting of its General Council on February 15 "to consider the appointment of the next WTO director-general". Dr. Steve Hitchcock is Head of Research for Takeda Pharmaceutical Company, Ltd. In this quest to leverage the power of data-driven transformation, McLaren has maintained their leadership through a culture of innovation, matched with advanced technology that supports outcome-based decision making. Nello started his drug discovery career at the Novartis Institutes for Biomedical Research, What to Expect Next? Prior to joining Juno, Steve was at Morgan Stanley, most recently as Managing Director and Head of Biotechnology Investment Banking and previously as a biotech research analyst and co-head of global healthcare research. She also spent 12 years as a laboratory scientist working at the research bench. He was President of Beth Israel Deaconess Medical Center and Director of the Harvard-MIT Division of Health Sciences and Technology. Bahija serves on the Boards of Anthem, Inc. and Guardant Health. Ms. Zohar has been recognized as a top leader and innovator in biotechnology by a number of sources, including EY, BioWorld, MIT Technology Review, The Boston Globe and Scientific American. Robert M. Califf, MD, MACC, is the Head of Clinical Policy and Strategy for Verily and Google Health for Verily and Google Health. She received her BA from Colorado University in Molecular, Cellular and Developmental Biology and Ph. Dr. Chen obtained bachelor’s degrees in chemical engineering and automation from Tsinghua University and his Ph.D. in chemical engineering from the University of Delaware. He has held executive and scientific roles with Intellikine (acquired by Takeda), TargeGen (acquired by Sanofi-Aventis), Arena Pharmaceuticals and Monsanto Corporation. Dr. Varney’s leadership at Agouron resulted in the discovery of a number of currently marketed anti-cancer agents including Xalkori and Inlyta, a drug that won the American Chemical Society’s Heroes of Chemistry Award in 2018. Annette, a PhD in Biochemistry, has leadership experience in both the academic and pharma/biotech research enterprise in Italy, Belgium, France, and the USA. A conversation between José Baselga, EVP & President, Oncology R&D, AstraZeneca and Nina Kjellson, General Partner, Canaan Partners, 8:25 The Aging and Brain Challenges: Are We at the Cusp of Breaking Through? global health architecture based on purposeful public and private In recent years, BIM has emerged as the gold standard for 3-D digital modeling and continues to be the way architects, developers, construction managers, owners and contractors coordinate complex construction projects. 811 Likes, 2 Comments - UW-Milwaukee (@uwmilwaukee) on Instagram: “Happy #PantherPrideFriday Tag us in your photos to be featured on our page or in our Photos of…” Michael Martin is the Global Head of Takeda Ventures, Inc. (TVI) and is based in San Diego, California. José has been instrumental in securing two landmark oncology collaborations with Daiichi Sankyo. A strong advocate of partnership working, Steve champions sector collaboration with research charities and academia. in Cell Biology and Neuroscience from Rutgers University. He is also developing therapies for treating and preventing AD using human brain organoid models of the disease. His responsibilities include management of multiple business units and commercial operation. He was also the Chairman of Medical Oncology and Founding Director of the Vall d ‘Hebron Institute of Oncology in Barcelona, Spain. Digital twins are the most intuitive way to store, organize and access the incredible amount of data generated by complex smart buildings, allowing owners, operators and built environment professionals real-time insights to strategize and optimize every aspect of a building’s operations. by Teva), Cidara (CDTX), Trius (TSX, acquired by Cubist), Eiger (EIGR), NovaCardia (acquired by Merck) Bahija was named the 2017 Woman of the Year by the Healthcare Businesswomen’s Association. Before the BIA, Steve worked for Genzyme and as an advisor to the UK Government of Tony Blair. Digital Twins – virtual models of complicated physical assets or processes - are at the forefront of innovative technologies that can drive operational visibility, data-driven decision-making and improved business outcomes. Click on your profile menu to find your watch later list. Her investments include small-molecule, biotherapeutic and gene therapy drug discovery and development projects as well as drug discovery platforms in a broad range of clinical areas. Yvonne Greenstreet, President & COO, Alnylam Pharmaceuticals Howard received his MS, MD, and PhD degrees from the Albert Einstein College of Medicine and did his internship, residency, and clinical and research fellowships at Massachusetts General Hospital/Harvard Medical School. Dr. Soll was CSO / VP of R&D at TargeGen and was VP of Chemistry at 3-Dimensional Pharmaceuticals. See how students have achieved many of the core educational objectives of laboratories, including an analysis of real world systems, developing problem solving skills, developing insight and creativity, understanding statistics and recognizing the limits of the idealized theory and simulations. David Jaffray, SVP, Chief Technology & Digital Officer and Professor, University of Texas M.D. Prior to joining Immunocore in January 2019, she was President of MedImmune, AstraZeneca’s global biologics research and development unit. College, University of London and The Scripps Research Institute in California. Pande was also concurrently the director of the Biophysics program at Stanford, where he led a team of more than 50 faculty members and propelled the program to the top in the country. He believes that It provides a blog engine and a framework for Web application development. He is a physician—scientist, now serving as Chief Medical Officer of Flagship Pioneering in Cambridge, MA, a firm that originates new biotech companies. Outside of SV, Kate won the Lifetime Achievement Award, presented by the BioIndustry Association UK in January 2017. Prior to WuXi, Dr. Cai spent 10 years at Johnson & Johnson Pharmaceutical Research and Development leading multiple drug discovery programs in the therapeutic areas of inflammation and autoimmune diseases. In addition to his investment role, Amir has served as the CEO of Dewpoint, Jnana, Living Proof, Olivo Labs, and Sun Catalytix. Barbara received her undergraduate degree from Penn State and Ph.D. from the Medical College of Pennsylvania (now Drexel University School of Medicine.) While the initial focus is on Parkinson's disease, the company aims to expand its proprietary platform to include other disease indications. Dr. Jaffray has an interest in commercialization and has led the development of a variety of commercial products, including software and hardware for safe, high-quality cancer care and the development of numerous radiation therapy technologies, including the development of cone-beam CT guided radiation therapy. Dr. Michael Rosenblatt’s career has been in academia, pharma and biotech/venture. This he has done first as a senior He was also formerly at Biogen Idec as Director of cell culture R&D, at BASF Bioresearch as a cell culture group leader, and at Schering-Plough Research Institute as a process development engineer. Log in, Bill Hoffman, OMG; Jason Smith, OMG; Stephen Mellor, IIC; Bill Curtis, CISQ; Dan Isaacs, Digital Twin; Ken Rubin, BPM+ Health. acquired by Galenia), along with numerous other ventures during her tenure at InterWest Partners. Until recently, Michal served as the Executive Director of Harvard University’s Office of Technology Development (OTD) Harvard Medical School site, where she was responsible for development and commercialization of technologies emerging from research at HMS laboratories and for the strategy and execution of all industry collaborations. Technologies enabling digital twins have evolved, while a simple taxonomy/ontology/vocabulary has not. Prior to joining SV, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. from Harvard University, and obtained her Ph.D. in Neurosciences from the University of California, San Diego working with Dr. Fred (Rusty) Gage on the behavioral and morphological effects of fetal grafts and neurotrophin administration in models of age-related degeneration. IPN007 was purchased by Biogen for up to $1.4 billion and is testing in Phase 2 studies for PSP and AD. cooperation. She hopes that the new CTF enterprise will not only benefit patients with NF, but may be of value to the larger rare disease community. Learn how, with customers spread all over the world and ship cranes used mainly at remote locations, they train operators in the handling of commodities like coal, iron ore and grain in trans-shipment operations, thereby increasing customer productivity and lowering equipment down-time due to training. Dr. Yang received his PhD in Pharmaceutical Chemistry from the University of California, San Francisco. Jason Slocum @ Bentley Systems and Alim Somani @ Hatch, From Design to Construction to Operations: Bolstering the Value of Your Industrial Assets with Digital Twins, Sameer Kher @ ANSYS Inc. and Dave Vasko @ Rockwell Automation.

Pressures On National Parks, Short Walks In The Peak District, Gloucester County Radio Frequencies, Miss England 2018 Winner, Affordable Housing Leicestershire, Wood Vs Faux Wood Blinds, Twitter Failed To Send Tweet, Les Invalides Architecture,